STRS Ohio’s Day One Biopharmaceuticals DAWN Stock Holding History

STRS Ohio’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-37,900	Closed	-$813K	–	2202
2026 Q1	$813K	Buy	37,900 +9,800	+35%	+$138K	﹤0.01%	781
2025 Q4	$262K	Buy	+28,100	New	+$235K	﹤0.01%	1399
2023 Q2	–	Sell	-2,300	Closed	-$30K	–	1982
2023 Q1	$30K	Buy	+2,300	New	+$44.9K	﹤0.01%	1834
2022 Q1	–	Sell	-2,500	Closed	-$42K	–	2157
2021 Q4	$42K	Hold	2,500	–	–	﹤0.01%	2024
2021 Q3	$59K	Buy	+2,500	New	+$59.9K	﹤0.01%	2044

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

STRS Ohio's DAWN Position: Q2 2026 in Review

STRS Ohio sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 37,900 shares — an estimated $813K sold.

STRS Ohio first reported a position in DAWN in Q3 2021 and held it in 5 quarters. The position peaked at $813K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

STRS Ohio reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
STRS Ohio sold 37,900 Day One Biopharmaceuticals shares in Q2 2026, an estimated $813K.
STRS Ohio first reported a position in Day One Biopharmaceuticals in Q3 2021 and held it in 5 quarters.
STRS Ohio's Day One Biopharmaceuticals position peaked at $813K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.